Skip to main content

StemPoint Capital LP

SEC CIK
0001952142
Latest filing
Aug 14, 2026

RLMD holding history

Relmada Therapeutics, Inc. in every 13F filed by StemPoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings

Shares (Q2 2026)
1,460,093
Value
$10.1M
% of portfolio
1.7%
Quarters held
2
Since Q1 2026
Holdings of RLMD by StemPoint Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,460,093$10.1M1.7%+862,684+144.4%AddedHolders
Q1 2026597,409$4.16M0.8%+597,409NewHolders